This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American CareSource Announces Financial Results For First Quarter 2012

American CareSource Holdings (NASDAQ: ANCI), the leading national network of ancillary healthcare providers, today reported revenue of $9.4 million for the first quarter of 2012, compared to $13.1 million for the same period in 2011. Net loss for the quarter was $558,000 compared to a net loss of $222,000 for the prior-year period.

Today, approximately 60 percent of employees with health insurance are covered by an employer’s self-funded plan. The growth among self-insured employers, as well as the ongoing implementations of recent healthcare reforms, has emphasized the need for healthcare cost containment, which is a primary function of third-party administrators (TPAs). During the first quarter, the company continued to focus on meeting the needs of TPAs and the direct payor market, primarily through its network of ancillary service providers. This strategy is supported by the size of the market.

During the first quarter, revenue from the company’s TPA clients grew $924,000 or 24 percent, and ACS added another new TPA client, as well as significantly increased its pipeline of prospects within the market. The company continued to focus on controlling costs and preserving its cash reserves. It reduced its non-variable cost structure 6 percent, despite significant investments in its sales function, and generated approximately $168,000 of positive cash flow.

Kenn S. George, CEO and Chairman of the Board, stated, ”While I continue to be disappointed in the decline in our overall top-line revenue due to continued pressures on our legacy PPO clients, and the length of our sales cycle, I am very encouraged by the growth from clients in our target market. We continue to focus on bringing value to a sizable market for our core business, primarily through our ancillary network, but also through DiaSource, our new solution for controlling dialysis costs.”

First Quarter Highlights

  • Revenue from TPA clients grew $924,000, or 24 percent, compared to first quarter of 2011.
  • As previously announced, ACS engaged JMG Management Group to consult on the process of transforming ACS' sales function. In addition, two new sales representatives were added early in the quarter.
  • As previously announced, as part of the company’s new DiaSource program, a participating provider hosted its first patient. The relationship was facilitated by a benefits broker, which was identified as an additional sales channel.
  • ACS completed development of a proprietary software connection to a major claims adjudication system that will simplify and accelerate implementations with clients and prospects that utilize that system.
  • ACS continued to control headcount through natural attrition; headcount at March 31, 2012 was 54 employees, compared to 57 employees at December 31, 2011 and 64 employees at March 31, 2011.
  • ACS generated positive cash flow and ended the quarter with $11.5 million of cash and cash equivalents.

Net Revenue

Overall, net revenue was $9.4 million for the first quarter of 2012 compared to $13.1 million in the same period in 2011. Non-legacy accounts (added in 2010-2012) generated $3.8 million and grew 40 percent compared to the first quarter of 2011, representing early success of the company’s strategy to focus on the TPA and direct payor market. The growth in these accounts was primarily due to two clients that generated full claims flow in the first quarter of 2012, compared to early 2011 when the accounts were in the implementation phase. In addition, several clients added incremental employer groups that were previously not utilizing ACS’ network of ancillary service providers.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs